Vedic Ayurveda AGM agenda: Deepika Awasthi to become MD, Rs 100 crore borrowing limit
- Vedic Ayurveda AGM scheduled for Oct 30, 2026, via VC/OAVM
- Proposal to make Deepika Awasthi Managing Director for 5 years
- Shareholders to approve ₹100 crore borrowing and security limits
- FY26 net loss of ₹2.10 lakh vs ₹4.30 lakh in FY25; zero revenue
- Company renamed from KD Leisures to Vedic Ayurveda in June 2026

*this image is generated using AI for illustrative purposes only.
Vedic Ayurveda Limited, formerly KD Leisures Limited, has released its notice for the 45th Annual General Meeting scheduled for October 30, 2026. The agenda includes a proposal to change Deepika Awasthi's designation from Executive Director to Managing Director and seeks shareholder approval for borrowing limits up to ₹100 crore.
The company reported a net loss of ₹2.10 lakh for FY26, an improvement from the ₹4.30 lakh loss in FY25, with zero operational revenue in both years. The meeting will be held via Video Conferencing, with remote e-voting open from October 27 to October 29, 2026.
Leadership changes and governance updates
The board proposes a special resolution to appoint Deepika Awasthi as Managing Director for a five-year term effective October 29, 2026. She currently serves as Executive Director and retires by rotation at this meeting. Additionally, the board seeks regularisation of Atul Chauhan as an Independent Director for a five-year term commencing October 7, 2026. Shekhar Chandrakant More was appointed as Chief Financial Officer effective October 7, 2026, replacing Mandeep Singh Thukral, who resigned from the CFO role on April 10, 2026.
Financial performance and strategic shift
The company remains inoperative regarding core business activities, generating no revenue from operations in FY26 or FY25. Total expenses declined to ₹2.10 lakh from ₹4.30 lakh in the previous year, primarily due to lower other expenses. The auditors issued a qualified opinion citing non-receipt of confirmations for loans and advances and non-compliance with Income Tax Act filing requirements for assessment years 2021-22 onwards.
Subsequent to the financial year-end, the company changed its name from KD Leisures Limited to Vedic Ayurveda Limited and altered its object clause to include Ayurveda, herbal products, and healthcare businesses. A certificate dated July 14, 2026, notes that income from new business activity (Ayurveda sessions) stood at ₹15.00 lakh for Q1FY27.
Borrowing powers and security creation
Shareholders are asked to approve increasing the limit for creating charges on assets to secure borrowings up to ₹100 crore. This supersedes earlier resolutions and allows the board to mortgage or pledge movable and immovable assets. Concurrently, the company seeks approval to borrow funds up to ₹100 crore through debentures, term loans, or inter-corporate deposits. Approval is also sought to provide loans, guarantees, or securities up to ₹100 crore to subsidiaries, associates, or entities where directors are interested.
Key dates and procedural framework
The register of members will remain closed from October 24, 2026 to October 30, 2026. The cut-off date for remote e-voting eligibility is October 23, 2026. Remote e-voting will commence on October 27, 2026, at 9:00 am and conclude on October 29, 2026, at 5:00 pm.
| Event | Date | Time |
|---|---|---|
| Cut-off date for eligibility | October 23, 2026 | N/A |
| Book closure start | October 24, 2026 | N/A |
| Remote e-voting start | October 27, 2026 | 9:00 am |
| Book closure end / E-voting end | October 29, 2026 | 5:00 pm |
| 45th Annual General Meeting | October 30, 2026 | 3:00 pm |
What the Numbers Show
The combined data reveals a stark divergence between the company's historical balance sheet strength and its current operational reality. While the company holds significant assets, including loans of ₹176.50 lakh and cash of ₹8.05 lakh, it generated zero revenue in FY26. The proposed ₹100 crore borrowing limit is disproportionately large compared to the paid-up capital of ₹3.24 crore and total equity of ₹159.76 lakh, signaling a potential pivot toward aggressive capital deployment or restructuring following the name change and diversification into the Ayurveda sector.
How will the company address the auditors' qualified opinion regarding non-compliance with Income Tax Act filing requirements for assessment years 2021-22 onwards?
What specific capital allocation strategy will Deepika Awasthi implement to deploy the proposed ₹100 crore borrowing limit given the company's current lack of operational revenue?
Can the Q1FY27 revenue of ₹15.00 lakh from Ayurveda sessions be scaled sufficiently to justify the aggressive expansion into the healthcare sector?



























